What is iRadimed's revenue?

iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.

Is iRadimed profitable?

iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.

What are iRadimed's profit margins?

Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.

What is iRadimed's earnings per share?

iRadimed's diluted EPS over the trailing twelve months is $1.83.

Where does iRadimed's income statement data come from?

Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

iRadimed IRMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$83.81M+14.4%	$73.24M+11.7%	$65.56M+23.0%	$53.3M+27.5%
Total cost of revenue	$19.49M+15.4%	$16.89M+9.7%	$15.4M+28.1%	$12.02M+23.1%
Gross profit	$64.32M+14.2%	$56.35M+12.3%	$50.16M+21.5%	$41.28M+28.8%
Gross margin	76.7%-0.2pp	76.9%+0.4pp	76.5%-0.9pp	77.4%+0.8pp
Research and development	$2.97M+5.0%	$2.83M-44.1%	$5.06M+122%	$2.28M+19.6%
Selling and marketing	$17.42M+11.6%	$15.62M+57.2%	$9.94M-21.6%	$12.68M+20.1%
General and administrative	$17.78M+11.6%	$15.94M+5.4%	$15.12M+41.4%	$10.7M+9.5%
Total operating expenses	$38.18M+11.0%	$34.39M+14.1%	$30.12M+17.4%	$25.65M+15.4%
Operating income	$26.15M+19.0%	$21.97M+9.6%	$20.04M+28.2%	$15.63M+59.2%
Operating margin	31.2%+1.2pp	30%-0.6pp	30.6%+1.2pp	29.3%+5.8pp
Other income (expense), net	$2.21M-4.2%	$2.31M+35.7%	$1.7M+208%	$553.1K+2,873%
Income before income taxes	$28.36M+16.8%	$24.28M+11.7%	$21.74M+34.3%	$16.18M+64.5%
Income tax expense	$5.88M+16.7%	$5.04M+10.9%	$4.55M+35.6%	$3.35M—
Net income	$22.48M+16.9%	$19.23M+11.9%	$17.19M+34.0%	$12.83M+37.6%
Net margin	26.8%+0.6pp	26.3%0.0pp	26.2%+2.2pp	24.1%+1.8pp
Diluted earnings per share	$1.75+16.7%	$1.50+10.3%	$1.36+32.0%	$1.03+39.2%
EBITDA	$27.31M+19.9%	$22.78M+9.5%	$20.8M—	——
EBITDA margin	32.6%+1.5pp	31.1%-0.6pp	31.7%—	——
EBIT	$26.15M+19.0%	$21.97M+9.6%	$20.04M+28.2%	$15.63M+59.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about iRadimed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's revenue?: iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.
Is iRadimed profitable?: iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.
What are iRadimed's profit margins?: Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.
What is iRadimed's earnings per share?: iRadimed's diluted EPS over the trailing twelve months is $1.83.
Where does iRadimed's income statement data come from?: Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.